Investor Ideas, Trading Ideas and Stocks to Watch

Friday, November 01, 2019

The #AIEye: AWS (Nasdaq: $AMZN) Announces Infrastructure Region in Spain and MIT-IBM (NYSE: $IBM) #Watson Lab Research Reveals Impact of #AI Adoption on Jobs

The #AIEye: AWS (Nasdaq: $AMZN) Announces Infrastructure Region in Spain and MIT-IBM (NYSE: $IBM) #Watson Lab Research Reveals Impact of #AI Adoption on Jobs

AI in Healthcare to Reach $1.139 Billion by 2022

Point Roberts WA, Vancouver BC – November 1, 2019 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2019/110119-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2019/artificial-intelligence/11011AIEye-AMZN-IBM.asp

Hear the Ai Eye on Spotify

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NasdaqGS:AMZN) (NYSE:IBM)

Amazon Web Services (AWS), a subsidiary of Amazon (NasdaqGS:AMZN), has announced the opening of an infrastructure region in Spain featuring three Availability Zones at launch. It will give Spanish startups, enterprises, and the public sector the ability to “leverage advanced technologies including analytics, artificial Intelligence, database, Internet of Things (IoT), machine learning, mobile services, serverless, and more to drive innovation”. Peter DeSantis, Vice President of Global Infrastructure and Customer Support, Amazon Web Services, commented:

“Cloud computing is already powering innovation within businesses, educational institutions, public administrations, and government agencies across Spain, and with this AWS infrastructure region, we look forward to helping accelerate this transformation. Opening an AWS Region in Spain will drive more technology jobs and businesses, boosting the local economy, while enabling organizations across all industries to lower costs, increase security, and improve agility. We’re excited to have AWS contribute to the future growth of Spain.”

IBM (NYSE:IBM) has released research from the MIT-IBM Watson AI Lab – which is described as “a collaborative industrial-academic laboratory focused on advancing fundamental AI research” – finding that AI will change the job landscape, but won’t actually eliminate many jobs. Martin Fleming, vice president and chief economist of IBM, commented:

"As new technologies continue to scale within businesses and across industries, it is our responsibility as innovators to understand not only the business process implications, but also the societal impact. To that end, this empirical research from the MIT-IBM Watson AI Lab sheds new light on how tasks are reorganizing between people and machines as a result of AI and new technologies."

The research finds that low-wage and high-wage occupations are actually experiencing increases in earnings as AI adoption progresses, whereas mid-wage jobs are the ones being “squeezed”.

AI in Healthcare to Reach $1.139 Billion by 2022

A report from Trends Market Research finds that the global AI in Healthcare market will reach $1.139 billion by 2022 with a compound annual growth rate (CAGR) of 62.2 percent in the forecast period 2016-2022. The following excerpt from the report description outlines the technology associated with the market:

The AI technology is leading towards innovation of efficient and inexpensive healthcare solutions. The major technologies involved are natural language processing, machine learning, biometric security, speech recognition and disaster recovery. The technology providers are heading towards development of innovative products and solutions for end-users. At present, NLP market is having the major share with an estimated increase to $487.7 million by 2022 growing at a CAGR of 61.6%. The increase in adoption of cloud computing, internet and innovation in network connectivity is driving the adoption of NLP in healthcare sector. Besides, NLP the second most prominent technology in healthcare is machine learning which is expected to reach $223.7 million by 2022, growing at a CAGR of 61.9%. Based on end users, the market encapsulates diagnostic centres, hospitals and clinics, R&D and healthcare institutes. AI finds wide application in precision medicine, real- time monitoring, drug development and personal health assistants.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800 665 0411

Get more tech stocks investor ideas- news, articles, podcasts and stock directories

#CryptoCorner: HIVE (TSXV: $HIVE.V) Appoints New Board Member, Long #Blockchain (OTC: $LBCC) Signs Intent to Merge with Stran Promotional Solutions and Telegram Debuts Test Desktop Wallet for Gram Token

#CryptoCorner: HIVE (TSXV: $HIVE.V) Appoints New Board Member, Long #Blockchain (OTC: $LBCC) Signs Intent to Merge with Stran Promotional Solutions and Telegram Debuts Test Desktop Wallet for Gram Token

Point Roberts, WA, Delta BC November 1, 2019 - Investorideas.com, a leader in crypto and blockchain investing news brings you today’s edition of the Crypto Corner podcast and commentary on what’s driving the cryptocurrency market .

Listen to today’s Crypto Corner Podcast:

https://www.investorideas.com/Audio/Podcasts/2019/110119-CryptoMarket.mp3

Read this in full at https://www.investorideas.com/news/2019/crypto-corner/11011HIVE-LBCC-Telegram.asp

Get the Crypto Corner Podcast on iTunes

Stocks discussed: (TYO:8473) (TSXV:HIVE) (OTC:LBCC)

SBI Holdings, Inc. (TYO:8473) released a report indicating its financial results in the six months ending on September 30, 2019. According to the report, SBI VC Trade – which includes the company’s crypto asset exchange – contributed a surge in profits to 3.246 billion yen (roughly $30 million USD) from a loss of 765 million yen ($7.1 million USD). An excerpt from the report reads:

“SBI VC Trade, which became a subsidiary of SBI SECURITIES from July of this year, has continued its steady performance, and SBI Crypto, which performs crypto-asset mining, has maintained its profitability. Other crypto asset-related businesses are in preparation, in anticipation of the revisions in the Financial Instruments and Exchange Act, and in the Payment Services Act, which are scheduled to be enacted in April 2020”

HIVE Blockchain Technologies Ltd. (TSXV:HIVE) has appointed Mr. Dave Perrill to its board of directors. According to the press release, “Perrill is the founder and CEO of Compute North, a rapidly growing data center company that offers low-cost and efficient infrastructure services for clients in the blockchain, cryptocurrency mining and the broader high-performance computing space”. Frank Holmes , HIVE's Interim Executive Chairman, commented:

"Mr. Perrill provides HIVE with significant expertise in helping cryptocurrency miners maximize large-scale data center operations with improved operational efficiency, a vast knowledge of the North American electrical power and cryptocurrency mining environment, as well as IT, information security, and business expertise. We are very pleased to welcome him to the Board and add to our independent industry experience."

Long Blockchain Corp. (OTC:LBCC) has entered into a non-binding letter of intent to merge with private comprehensive branding and incentive solutions-provider Stran Promotional Solutions. Andy Shape, CEO and a director of LBCC as well as the President of Stran, commented:

“We’re excited to expand Stran’s visibility through this proposed transaction. We bring more than 25 years of experience building strong partnerships, cutting-edge technology solutions and innovative custom branding programs that help our customers extend the loyalty of their brands. We see this transaction as an ideal platform for further growth opportunities for the Stran family – including our partners, customers, employees and current and future shareholders.”

Messaging company Telegram has debuted a test app desktop wallet for its gram token. According to a report from CoinDesk, users can “get testnet grams from a special Telegram bot, asking it to send from 5 to 20 tokens”. The TON blockchain project, which raised $1.7 billion via token sale, was due to launch on October 31, but was prevented when the U.S. Securities and Exchanges Commission (SEC) “deemed grams to be unregistered securities and asked the court to prevent Telegram from delivering tokens to investors”.

Sam Mowers, Investorideas

For investors following the sector Investor Ideas has a comprehensive Bitcoin, Blockchain and Digital Currency Stocks Directory

The Crypto Corner is part of the Investor Ideas Membership content

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Cryptocurrency Disclaimer

Investorideas.com news content is not meant to be a solicitation to buy or sell cryptocurrencies and Investorideas.com does not directly sell cryptocurrencies; but acts as a news and research resource for interested investors following the blockchain sector.

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800-665-0411

Get more Bitcoin and Blockchain Investor ideas – news, articles, podcasts and stock directories

#Cleantech and #Climate Change #Podcast interview with Graciela Chichilnisky, Co-author of REVERSING CLIMATE CHANGE, @Fridays4future

#Cleantech and #Climate Change #Podcast interview with Graciela Chichilnisky, Co-author of REVERSING CLIMATE CHANGE, @Fridays4future

A Quest for a Carbon Revolution

Point Roberts WA, Delta BC, November 1, 2019 – Investorideas.com, a global news source and leading investor resource issues a special edition of its Cleantech and Climate Change podcast, talking to well-known thought leaders and management of publicly traded about today's problems and solutions for the future.

Today’s podcast features an exclusive interview with renowned economist Graciela Chichilnisky, co-author of the forthcoming book REVERSING CLIMATE CHANGE (World Scientific Publishing, December 2019).

Chichilnisky also talks about her company, Global Thermostat and its “direct air capture" technology that removes CO2 from the atmosphere; how it works and its current status. This technology could potentially play a role in a carbon revolution. Chichilnisky believes economics and climate change need to go hand-in-hand.

CO2 removed from the air will not only potentially reverse climate change but can become the main feedstock of economic growth, replacing petroleum.

A fair global economic playing field and a reversal of climate change; now that is a revolution!

Listen to the Podcast interview

https://www.investorideas.com/Audio/Podcasts/2019/103019-CleanTech.mp3

Read this in full at https://www.investorideas.com/news/2019/cleantech-climatechange/11011Interview-GracielaChichilnisky.asp

ABOUT THE AUTHORS

Dr. Graciela Chichilnisky, co-author of REVERSING CLIMATE CHANGE, is a Professor of Economics and Mathematical Statistics at Columbia University, and Director of the Columbia Consortium for Risk Management. She is also co-founder and CEO of Global Thermostat, and co-creator of a carbon removal technology that the National Academy of Sciences has said is the only one that can reverse climate change. The technology was chosen by MIT Technology Review as one of the Ten Breakthrough Technologies of 2019, curated by Bill Gates. In addition, Global Thermostat was named one of the top ten most innovative companies in energy by Fast Company and Dr. Chichilnisky was selected by International Alternative Investment Review as the 2015 CEO of the Year in Sustainability. In 2019, Global Thermostat and ExxonMobil signed a joint development agreement to advance breakthrough technology to scale up to the removal of 1 gigaton of CO2.

Chichilnisky worked extensively on the Kyoto Protocol, creating and designing the carbon market that became international law in 2005. In 2017, she was selected by the Carnegie Foundation for their prestigious Great Immigrant, Great American award and in 2018, she was awarded the Albert Nelson Marquis Lifetime Achievement Award.

Chichilnisky holds Ph.D. degrees in mathematics and economics from MIT and the University of California, Berkeley. She is the author of more than 300 scientific articles and 13 books, including Saving Kyoto which won the American Library Association’s 2010 Outstanding Academic Title of the Year and the American Geographical Society’s Book of the Month Award in October 2009. She acted as the lead author on the Intergovernmental Panel on Climate Change which received the 2007 Nobel Prize for its work in deciding world policy with respect to climate change.

Peter Bal, co-author of REVERSING CLIMATE CHANGE, is a businessman and ecological restoration practitioner. He sees carbon dioxide as an asset to be mined, focusing on natural plant absorption as well as industrial solutions to retrieve carbon dioxide from the atmosphere. He is currently working on a containerized carbon dioxide absorbing unit with Global Thermostat and also involved in setting up ecological research and training centers.

Investor Ideas has created a stock directory of publicly traded cleantech stocks for investors to use as a research tool to start trading and investing in the sector. Visit http://www.investorideas.com/membership/ to learn more about our stock directories in leading sectors.

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Sticher, Spreaker.com, iHeart.com and Google Play Music.

Visit the Podcast page at Investorideas.com: http://www.investorideas.com/Audio/

Subscribe to Investorideas.com Podcast RSS:

http://www.investorideas.com/rss/feeds/Podcasts.xml

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800 665 0411

RenewableEnergyStocks.com: investing ideas in renewable energy stocks

Like Renewable Energy Stocks? View our

Renewable Energy Stocks Directory

Get News Alerts on Renewable Energy Stocks

Investor Ideas adds New #Stocks in Cannabis (CSE: $MXT.C) (CSE: $PRMO.C), Biotech (Nasdaq: $IPHA, $VIR, $BNRX, $FREQ) and Tech (CSE: $AMPD.C) (CSE: $TKR.C)

Investor Ideas adds New #Stocks in Cannabis (CSE: $MXT.C) (CSE: $PRMO.C), Biotech (Nasdaq: $IPHA, $VIR, $BNRX, $FREQ) and Tech (CSE: $AMPD.C) (CSE: $TKR.C)

Point Roberts WA, Delta BC, November 1, 2019 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces its weekly roundup of stocks added to its global stock directories in cannabis, biotech and tech.

Read this in full at https://www.investorideas.com/news/2019/main/11011Stocks.asp

This week’s new cannabis companies are both CSE-listed and are involved in CO₂extraction and financing for the cannabis industry, respectively.

The latest biotech/life sciences companies are all October Nasdaq IPOs.

The newest tech companies are both CSE-listed and are involved in cloud computing and IoT & AI, respectively.

New Cannabis Companies:

MedXtractor Corp. (CSE:MXT) is a Calgary-based company that manufactures patented, proprietary small-scale carbon dioxide-based extractors that are used to extract essential oils and compounds from a variety of botanical materials. At present, the Corporation targets the "Craft" cannabis grower. Craft growers are those whose crop is up to 800 indoor-sized plants per crop cycle. In management's opinion, CO2 Extractors represent the state-of-the-art for high-potency, high-purity oils, one of the fastest growing segments of the overall cannabis market. Cannabis oils can be extracted from flowers (bud), trim (leaves) and/or post-pressed rosin "chips" (leftovers from hydraulic press extraction). The ongoing worldwide legalization of cannabis is underpinning the rapidly growing demand for cannabis products with major growth seen in oils due to their utility as feedstock for various ingestion methods. The Corporation owns the patents on its CO2 Extractors.

Primo Nutraceuticals Inc. (CSE:PRMO) formerly Bougainville Ventures Inc - provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. We offer fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Cultivators lease these facilities and pay affordable fee-based management costs to accelerate market entry and scalability. The first 10,000 square feet of greenhouse space in Oroville, Washington has been completed and is ready for occupancy. Our facilities remove financial barriers for cannabis cultivators as traditional funding is limited due to United States federal laws and current lending practices.

New Biotech Companies:

INNATE PHARMA SA (NasdaqGS: IPHA) is a commercial stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma’s commercial-stage product, Lumoxiti, in-licensed from AstraZeneca, was approved by the FDA in September 2018. Lumoxiti is a first-in class specialty oncology product for hairy cell leukemia (HCL). Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need. Innate Pharma has been a pioneer in the understanding of NK cell biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb, Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.

VIR BIOTECHNOLOGY, INC. (NasdaqGS:VIR) is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of five product candidates targeting hepatitis B virus, influenza A, human immunodeficiency virus and tuberculosis

BIONTECH SE (NasdaqGS:BNTX) was founded in 2008 on the understanding that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. Its cutting-edge pipeline includes individualized mRNA-based product candidates, innovative chimeric antigen receptor T cells, novel checkpoint immunomodulators, targeted cancer antibodies and small molecules. BioNTech has established relationships with seven pharmaceutical collaborators, including Eli Lilly and Company, Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Genevant and Pfizer, and has published over 150 peer-reviewed publications on its scientific approach.

FREQUENCY THERAPEUTICS, INC. (NasdaqGS:FREQ) is a leader in the development of medicines designed to activate progenitor cells within the body to treat degenerative diseases. The company’s progenitor cell activation (PCA) approach stimulates progenitor cells to create functional tissue with the aim of developing disease modifying therapies. The company’s lead product candidate, FX-322, is designed to regenerate auditory hair cells to restore hearing function. In a FX-322 Phase 1/2 study, the company observed statistically significant and clinically meaningful improvement in key measures of hearing function in patients with sensorineural hearing loss. The company is evaluating additional diseases where its PCA approach could create functional tissue, including a development program in multiple sclerosis. Headquartered in Woburn, Mass., Frequency has a development and commercialization agreement with Astellas Pharma Inc. for FX-322, for which it retains U.S. rights, as well as additional collaboration agreements with academic and nonprofit research organizations including The Scripps Research Institute, Massachusetts Eye and Ear, and the Massachusetts Institute of Technology.

VIELA BIO, INC. (NasdaqGS:VIE) headquartered in Gaithersburg, Maryland, is a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases.

APREA THERAPEUTICS, INC. (NasdaqGS:APRE) is a biopharmaceutical company headquartered in Boston, Massachusetts with research facilities in Stockholm, Sweden, focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53. The Company’s lead product candidate is APR-246, a small molecule in clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).

Neovasc, Inc. (TSX: NVCN.TO; NASDAQ: NVCN) is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include Reducer, for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and Tiara, for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada, Israel and Europe.

New Tech Companies:

AMPD Ventures Inc. (CSE:AMPD) specializes in providing high-performance cloud and compute solutions for low-latency applications including video games and eSports, digital animation and visual effects, and big data collection, analysis and visualization.

Tracker Ventures Corp. (CSE:TKR) – formerly TrackLoop - is an analytics software company that is leveraging digital asset technology to transform and modernize multiple industries. TrackLoop is taking a diversified approach to the analytics and technology space, delivering practical solutions in the finance, logistics, cannabis, and pharmaceutical industries. The Company’s turnkey real-time tracking solutions offer the very latest in IoT and AI, providing valuable data and business intelligence to some of the world’s leading brands.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

Download our Mobile App for iPhone and Android

To sponsor a daily podcast for the month or to be an expert guest please contact us!

Contact Investorideas.com

800-665-0411

About Investorideas.com

About Investorideas.com - Big Investing Ideas Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

Disclaimer/disclosure

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas, Trading Ideas and Stocks to Watch

Friday, November 01, 2019

The #AIEye: AWS (Nasdaq: $AMZN) Announces Infrastructure Region in Spain and MIT-IBM (NYSE: $IBM) #Watson Lab Research Reveals Impact of #AI Adoption on Jobs

#CryptoCorner: HIVE (TSXV: $HIVE.V) Appoints New Board Member, Long #Blockchain (OTC: $LBCC) Signs Intent to Merge with Stran Promotional Solutions and Telegram Debuts Test Desktop Wallet for Gram Token

#Cleantech and #Climate Change #Podcast interview with Graciela Chichilnisky, Co-author of REVERSING CLIMATE CHANGE, @Fridays4future

RenewableEnergyStocks.com: investing ideas in renewable energy stocks

Like Renewable Energy Stocks? View our

Renewable Energy Stocks Directory

Get News Alerts on Renewable Energy Stocks

Investor Ideas adds New #Stocks in Cannabis (CSE: $MXT.C) (CSE: $PRMO.C), Biotech (Nasdaq: $IPHA, $VIR, $BNRX, $FREQ) and Tech (CSE: $AMPD.C) (CSE: $TKR.C)

Blog Archive

Links

Search This Blog